<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to determine the prevalence of <z:e sem="disease" ids="C0018824" disease_type="Disease or Syndrome" abbrv="">cardiac valve disease</z:e> in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> or in patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and to assess the role of the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> as risk factor for endocardial lesions </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 39 consecutive patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (mean age 34 +/- 12 years, 38 female and one male), 20 women with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (mean age 32 +/- 4 years) and 20 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (mean age 35 +/- 8 years, 15 female and five male) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> had increased levels of serum anticardiolipin antibodies and recurrent fetal abortions; some of them also had arterial and/or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and/or <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>M-mode, two-dimensional and Doppler echocardiography were performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>IgG anticardiolipin antibodies were measured by an enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="5" pm="."><plain>Valvular lesions were observed in 15 patients (38%) with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>These abnormalities included: mitral valve thickening or vegetation, <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and aortic valve vegetation; mitral, aortic and <z:hpo ids='HP_0005180'>tricuspid regurgitation</z:hpo>; <z:hpo ids='HP_0001718'>mitral stenosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>None of the patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and of the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects was found to have <z:hpo ids='HP_0001654'>valvular abnormalities</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, high levels of anticardiolipin antibodies were detected in 73% of the patients with valvular lesions and in 67% of the patients without valvular lesions (P &gt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that valvular involvement is frequent in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> but it is apparently unrelated to antiphospholipid autoimmunization </plain></SENT>
</text></document>